Table 2 Univariate and multivariate analyses of risk factors for recurrence before propensity score matching.
Univariate | Multivariate | |||
|---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | |
Gender | ||||
Female | Ref. | |||
Male | 1.552 (1.066–2.259) | 0.022 | ||
Age (years) | ||||
> 45 | Ref. | Ref. | ||
≤ 45 | 2.192 (1.537–3.125) | < 0.001 | 1.841 (1.278–2.652) | 0.001 |
Extent of operation | ||||
Less than TT | Ref. | |||
TT and/or mRND | 1.821 (1.286–2.577) | 0.001 | ||
Tumor size | ||||
< 1 cm | Ref. | |||
≥ 1 cm | 2..136 (1.522–2.998) | < 0.001 | ||
ETE | 3.409 (2.140–5.432) | < 0.001 | 2.196 (1.305–3.695) | 0.003 |
Multifocality | 1.563 (1.114–2.193) | 0.010 | ||
Bilaterality | 1.744 (1.084–2.805) | 0.022 | ||
Lymphatic invasion | 3.202 (2.281–4.496) | < 0.001 | ||
Vacular invasion | 3.471 (1.822–6.611) | < 0.001 | 2.504 (1.286–4.876) | 0.007 |
Perineural invasion | 3.335 (1.632–6.815) | 0;001 | ||
Harvested LNs | 1.021 (1.014–1.028) | < 0.001 | ||
Positive LNs | 1.076 (1.063–1.088) | < 0.001 | 1.062 (1.041–1.083) | < 0.001 |
T stage | ||||
T1 | Ref. | |||
T2 | 2.488 (1.445–4.285) | 0.001 | ||
T3b | 3.649 (2.256–5.903) | < 0.001 | ||
T4a | 3.928 (0.548–28.173) | 0.173 | ||
N stage | ||||
N0 | Ref. | Ref. | ||
N1a | 4.350 (2.797–6.765) | < 0.001 | 3.159 (2.015–4.955) | < 0.001 |
N1b | 7.002 (3.738–13.116) | < 0.001 | 1.488 (0.630–3.512) | 0.364 |